"Thanks to ProBioGen's continuous support and regularly provided valuable information — not only on technical challenges but also urgent issues associated with the project — our teams were able to bring a product from their facility to clinic as scheduled, within several months, here in Japan."
Director, CMC Development | Chiome Bioscience Inc.
"Working with ProBioGen has been a highly rewarding experience. Their technical expertise, dedication to quality, and reliability, as well as industry-standard-exceeding results reaffirmed ProBioGen as the right partner for Marea. MAR002 holds promise as a first-in-class treatment for acromegaly, a life-shortening disease often with serious complications. We appreciate ProBioGen's support throughout the process and look forward to continuing our collaboration as we advance to the next stages."
Chief Development Operations Officer | Marea Therapeutics
